Yaoyao Gu

机构：China Mobile (China), Xiaomi (China) · ORCID：0000-0002-1682-2194

发表论文 21 篇 · 总被引 170 次 · h-index 8

代表论文

• PCLAF promotes neuroblastoma G1/S cell cycle progression via the E2F1/PTTG1 axis (2022 · Cell Death and Disease · 被引 53)
• MCM6 indicates adverse tumor features and poor outcomes and promotes G1/S cell cycle progression in neuroblastoma (2021 · BMC Cancer · 被引 27)
• CHILD syndrome mimicking verrucous nevus in a Chinese patient responded well to the topical therapy of compound of simvastatin and cholesterol (2018 · Journal of the European Academy of Dermatology and Venereology · 被引 18)
• P300 Interacted With N-Myc and Regulated Its Protein Stability via Altering Its Post-Translational Modifications in Neuroblastoma (2023 · Molecular & Cellular Proteomics · 被引 16)
• Identification of MYCN non-amplified neuroblastoma subgroups points towards molecular signatures for precision prognosis and therapy stratification (2024 · British Journal of Cancer · 被引 14)
• Pan‑cancer analyses reveal the regulation and clinical outcome association of PCLAF in human tumors (2022 · International Journal of Oncology · 被引 13)